Table 3 Adverse events following treatment with DHA–PPQ in Seacha, South West Ethiopia from May–August 2021
Adverse events | DHA–PPQ (n = 86) |
|---|---|
Fever | 5 (6%) |
Vomiting | 3 (4%) |
Abdominal pain | 3 (4%) |
Headache | 2 (2%) |
Skin rash | 2 (2%) |
Coughing | 1 (1%) |
Weakness | 1 (1%) |